San Francisco, California, February 27, 2018: A recent report by TMR Research, titled, “Thrombectomy Devices Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025”, offers a detailed outlook of this market on the grounds of the primary as well as secondary research.
Speaking of chief driving factors, the rapidly increasing geriatric population is highly contributing towards a rise in blood clot formation in the vascular systems of the patients. Owing to the use of thrombectomy devices in order to remove these blood clots, this rise in population is significantly pushing the associated thrombectomy devices market. A greater need for using the thrombectomy devices has been observed on the basis of several studies which noted the high occurrence of venous thromboembolism (VTE). Soaring cases of acute myocardial infarction, deep vein thrombosis, peripheral artery disease, and other disorders which may cause development of blood clots is also driving the advancement of the global thrombectomy devices market. With rapidly improving incomes among households, more families can now afford to handsomely spend for maintaining better healthcare. This changing attitude among people is also applicable in case of thrombectomy occurrences, thus positively contributing towards an improved market.
Get Sample Copy of this Report
Several governmental bodied all over the world are putting forth valuable initiatives that encourage the use of minimally non-invasive thrombectomy procedures, consequently augmenting the market. Improved medical reimbursement carried out in these cases has made people keep good faith on governmental as well as private healthcare centers and hospitals. This has greatly bolstered the global thrombectomy devices market by mushrooming reliability among patients and their kin regarding treatment processes.
On the other side, some governments have out forth stringent regulations on the sales of devices required for carrying out the thrombectomy processes. These regulations are also applicable to the manufacturing of the devices, and their distribution. This factor poses as a significant restraint on the global thrombectomy devices market. Less awareness among patients and overall communities regarding existence of thrombectomy techniques is a major hampering factor for the market. In such nations and regions, a shortfall of skilled and well-trained surgeons has been noticed, thus causing less growth in the global thrombectomy market. However, this picture is soon expected to change with several private as well as governmental bodies taking efforts to increase the reach and awareness of this treatment. These actions are expected to spark a hope for reducing the dampening effects caused by the restraints that are affecting the global thrombectomy devices market.
The global thrombectomy market is divided into five primary regional segment, viz. Europe, North America, Middle East and Africa, Latin America, and Asia Pacific. Owing to frequent use of technologically advanced products in the North American market for surgeons to carry out efficient thrombectomy processes, this region holds a commanding position with respect to maximum revenue gained. Strong healthcare infrastructure and surging cases clinical trial cases are also highly contributing towards a positive growth experienced in the North American market for thrombectomy devices.
Most of the players in the global thrombectomy devices market are looking at mergers and acquisitions as prime strategies in order to expand their product portfolio. Research and technological development are two areas where a lot of focus is being implemented by most players for improving their product portfolio. From and overall perspective, a significantly healthy and decently tough competitive scenario exists in the global thrombectomy devices market. Johnson and Johnson Inc., Medtronic Plc, Penumbra Inc., AngioDynamics Inc., Boston Scientific Corporation, Terumo Corporation, The Spectranetics Corporation, Vascular Solutions Inc., Teleflex Incorporated, and Stryker Corporation, are some of the most prominent players operating in the global thrombectomy devices market.